Propanc Biopharma, Inc. (PPCB) stock

PPCBNasdaqPharmaceutical PreparationsFiscal year ends June 30

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30

$1.94+0.02 (+1.09%)

Close on Nov 13, 2026Market cap $12.29MP/E –Yield –

Propanc Biopharma ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2013 it was -$1.36M.

Period	Period end	Value	Change
FY2013	Jun 30, 2013	-$1.36M	–
FY2012	Jun 30, 2012	-$11.59M	–
FY2011	Jun 30, 2011	-$2.23M	–

See a number that looks wrong?